Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Top
The paper's citation list
No.The paper's citation list
1Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3. 2019;10:437 doi: 10.1021/acsmedchemlett.8b00484
2Dihydroorotate dehydrogenase inhibitors in anti-infective drug research. 2019;183:111681 doi: 10.1016/j.ejmech.2019.111681
3Non-Steroidal Androgen Receptor Antagonists and Prostate Cancer: A Survey on Chemical Structures Binding this Fast-Mutating Target. 2019;26:6053 doi: 10.2174/0929867325666180913095239
4Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders. 2022;55:128448 doi: 10.1016/j.bmcl.2021.128448
5Pictet–Spengler condensations using 4-(2-aminoethyl)coumarins. 2020;44:13415 doi: 10.1039/D0NJ02664F
6Applications of Heterocycles in the Design of Drugs and Agricultural Products. 2021;134:185 doi: 10.1016/bs.aihch.2020.12.001
7Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer. 2020;26:56 doi: 10.3390/molecules26010056
8Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies. 2021;9:290 doi: 10.3390/biomedicines9030290
9Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target. 2020;8:569 doi: 10.3390/biomedicines8120569
10The expression of sex steroid receptors and sex steroid–synthesizing/metabolizing enzymes in metastasized lymph nodes of prostate cancer. 2019;84:124 doi: 10.1016/j.humpath.2018.09.011
11New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold. 2022;237:114366 doi: 10.1016/j.ejmech.2022.114366
12Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists. 2019;167:49 doi: 10.1016/j.ejmech.2019.01.054
13Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancer. 2021;36:127817 doi: 10.1016/j.bmcl.2021.127817
14Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid. 2018;150:930 doi: 10.1016/j.ejmech.2018.03.040
15Endocrine Disruptors and Prostate Cancer. 2022;23:1216 doi: 10.3390/ijms23031216
16 Computational modeling studies reveal the origin of the binding preference of 3‐(3,4‐di hydroisoquinolin‐2( 1H )‐ylsulfonyl)benzoic acids for AKR1C3 over its isoforms . 2022;31: doi: 10.1002/pro.4499
17Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo–keto reductase 1C3 target affinity. 2019;10:1476 doi: 10.1039/C9MD00201D
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties